A new strain that dominated the early winter was not well matched to the vaccine, leading to an intense early onslaught of ...

Conveyor Pulley Electric Generators (CPEG) produce an electrical current when driven in rotation during conveyor belt motion. As there is no need for engine power, kinetic energy from moving conveyor ...

Anthropic's Claude AI uncovered 22 Firefox vulnerabilities in a Mozilla partnership, demonstrating AI's growing role in cybersecurity.

This week in cybersecurity: stolen PlayStation accounts, AI chat transcripts sold by data brokers, tax-season scams, deepfake ...

Most Rust developers are satisfied with the pace of the language’s evolution, but many are concerned Rust does not get enough usage in tech, the 2025 State of Rust Survey says.

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Eli Lilly (NYSE:LLY) ...

The opt-in AI assistant can generate images, edit and translate text, and reorganize WordPress sites. The opt-in AI assistant can generate images, edit and translate text, and reorganize WordPress ...

Visual content has become a baseline expectation across marketing, ecommerce, publishing, and social platforms. What has changed is not the need for visuals, but the need to produce them more quickly ...

The new feature was spotted in Google Maps v26.05 It reportedly lets users make edits to a listing in plain words Gemini, then conversationally makes edits to the listing ...

BELTSVILLE, Md., Jan. 28, 2026 /CNW/ -- REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, ...

Greta Kerkhoff, editor in chief of the student newspaper at the University of Colorado at Boulder, was expecting to spend her final year of college working at the paper and completing her journalism ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...